Mostrar el registro sencillo del ítem

dc.contributor.authorCastillo Fernández, Nerea
dc.contributor.authorMartínez Pérez-Crespo, Pedro María
dc.contributor.authorSalamanca Rivera, Elena
dc.contributor.authorHerrera Hidalgo, Laura
dc.contributor.authorde Alarcón, Arístides
dc.contributor.authorNavarro Amuedo, María Dolores
dc.contributor.authorMarrodán Ciordia, Teresa
dc.contributor.authorPérez Rodríguez, María Teresa
dc.contributor.authorSevilla Blanco, Juan
dc.contributor.authorJóver Saenz, Alfredo
dc.contributor.authorFernández Suárez, Jonathan
dc.contributor.authorArmiñanzas Castillo, Carlos
dc.contributor.authorReguera Iglesias, José María
dc.contributor.authorNatera Kindelán, Clara
dc.contributor.authorBoix Palop, Lucía
dc.contributor.authorLeón Jiménez, Eva
dc.contributor.authorGalán Sánchez, Fátima 
dc.contributor.authordel Arco Jiménez, Alfonso
dc.contributor.authorBahamonde Carrasco, Alberto
dc.contributor.authorVinuesa García, David
dc.contributor.authorSmithson Amat, Alejandro
dc.contributor.authorCuquet Pedragosa, Jordi
dc.contributor.authorReche Molina, Isabel María
dc.contributor.authorPérez Camacho, Inés
dc.contributor.authorMerino de Lucas, Esperanza
dc.contributor.authorGutiérrez Gutiérrez, Belén
dc.contributor.authorRodríguez Baño, Jesús
dc.contributor.authorLópez Cortés, Luis Eduardo
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2024-02-21T12:00:12Z
dc.date.available2024-02-21T12:00:12Z
dc.date.issued2023-01-09
dc.identifier.issn2079-6382
dc.identifier.urihttp://hdl.handle.net/10498/31202
dc.description.abstractIt is not known whether sequential outpatient parenteral antimicrobial (OPAT) is as safe and effective as conventional hospitalization in patients with S. aureus bacteremia (SAB). A post-hoc analysis of the comparative effectiveness of conventional hospitalization versus sequential OPAT was performed in two prospective Spanish cohorts of patients with S. aureus bacteremia. The PROBAC cohort is a national, multicenter, prospective observational cohort of patients diagnosed in 22 Spanish hospitals between October 2016 and March 2017. The DOMUS OPAT cohort is a prospective observational cohort including patients from two university hospitals in Seville, Spain from 2012 to 2021. Multivariate regression was performed, including a propensity score (PS) for receiving OPAT, stratified analysis according to PS quartiles, and matched pair analyses based on PS. Four hundred and thirteen patients were included in the analysis: 150 in sequential OPAT and 263 in the full hospitalization therapy group. In multivariate analysis, including PS and center effect as covariates, 60-day treatment failure was lower in the OPAT group than in the full hospitalization group (p < 0.001; OR 0.275, 95%CI 0.129–0.584). In the PS-based matched analyses, sequential treatment under OPAT was not associated with higher 60-day treatment failure (p = 0.253; adjusted OR 0.660; % CI 0.324–1.345). OPAT is a safe and effective alternative to conventional in-patient therapy for completion of treatment in well-selected patients with SAB, mainly those associated with a low-risk source and without end-stage kidney disease.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceAntibiotics. Vol. 12, nº 1, January 2023, 129es_ES
dc.subjectbacteremiaes_ES
dc.subjectoutpatient parenteral antimicrobial therapyes_ES
dc.subjectStaphylococcus aureuses_ES
dc.titleConventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohortes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.description.physDesc14 páginases_ES
dc.identifier.doi10.3390/antibiotics12010129
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional